Cannabis

U.S. Federal Marijuana Policy Update: What Employers Should Know

On December 18, 2025, U.S. President Donald Trump signed an executive order directing U.S. federal authorities to reclassify marijuana from a Schedule I to a less restrictive Schedule III controlled substance under U.S. federal law. This is a significant shift in long-standing U.S. federal drug policy, but it does not currently affect any DOT testing protocols.  

Impairing Prescription Medication Use & Fitness for Duty

At the recent Oil Sands Expo, DriverCheck’s Chief Medical Officer, Dr. Jonathan W. Davids, shared important insights during his presentation “Medication Madness: Impairing Prescription Medication Use & Fitness for Duty.” His talk highlighted the often-overlooked risks that prescription medications can pose in safety-sensitive industries.